Literature DB >> 21959682

Changes in left ventricular preload, afterload, and cardiac output in response to a single dose of mannitol in neurosurgical patients undergoing craniotomy: a transesophageal echocardiographic study.

Nilay Chatterjee1, Thomas Koshy, Satyajeet Misra, Balethbail Suparna.   

Abstract

BACKGROUND: Mannitol increases intravascular volume by withdrawing water from the brain and causes significant changes in stroke volume, cardiac output (CO), systemic vascular resistance, central venous pressure (CVP), and blood pressure. No previous studies have demonstrated changes in left ventricular (LV) preload, afterload, and CO using transesophageal echocardiography (TEE).
METHODS: Fifteen adult patients undergoing elective supratentorial craniotomy received 20% mannitol 1.0 gm/kg over 15 minutes before dural opening. The following hemodynamic and TEE-derived parameters were recorded before and after the administration of mannitol: heart rate (HR), mean arterial pressure (MAP), CVP, LV end diastolic area (EDA), end systolic area, fractional area change, stroke volume, and CO.
RESULTS: EDA and CVP significantly increased at 5 minutes (P=0.002 and <0.001) after mannitol infusion and remained insignificantly elevated till 15 minutes, thereafter returning to baseline values. CO also increased significantly at 5 and 15 minutes (P=0.001 and 0.013) and remained insignificantly elevated till 25 minutes, and thereafter returned to baseline values. A concomitant significant decline in systemic vascular resistance was observed at 5 and 15 minutes (P=0.002 and 0.008 at 5 and 15 min, respectively). Although EDA increased significantly at 5 minutes, there were no appreciable changes in MAP and HR throughout the study period.
CONCLUSIONS: In conclusion, in patients undergoing craniotomy, TEE demonstrated that a single bolus dose of 20% mannitol (1.0 gm/kg) caused significant but short-duration alterations in LV preload, afterload, and CO without concomitant changes in hemodynamic variables (MAP/HR).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21959682     DOI: 10.1097/ANA.0b013e3182338b11

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  6 in total

Review 1.  Comparison of equiosmolar hypertonic saline and mannitol for brain relaxation during craniotomies: A meta-analysis of randomized controlled trials.

Authors:  Jingxue Fang; Yanzhang Yang; Wei Wang; Yang Liu; Tong An; Meijuan Zou; Gang Cheng
Journal:  Neurosurg Rev       Date:  2017-03-03       Impact factor: 3.042

2.  Use of a Minimally Invasive Cardiac Output Monitor to Optimise Haemodynamics in a Patient with Mitral Valve Disease Undergoing Cerebrovascular Surgery.

Authors:  Ali M Al-Mashani; Niranjan D Waje; Neeraj Salhotra; Samaresh Das; Neelam Suri; Rashid A Al-Sheheimi; Nilay Chatterjee
Journal:  Sultan Qaboos Univ Med J       Date:  2017-10-10

3.  Cardiac output changes after osmotic therapy in neurosurgical and neurocritical care patients: a systematic review of the clinical literature.

Authors:  Georgia Tsaousi; Elisabetta Stazi; Marco Cinicola; Federico Bilotta
Journal:  Br J Clin Pharmacol       Date:  2018-01-18       Impact factor: 4.335

Review 4.  Advanced monitoring of systemic hemodynamics in critically ill patients with acute brain injury.

Authors:  Fabio Silvio Taccone; Giuseppe Citerio
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

5.  The effect of mannitol on intraoperative brain relaxation in patients undergoing supratentorial tumor surgery: study protocol for a randomized controlled trial.

Authors:  Yuming Peng; Xiaoyuan Liu; Aidong Wang; Ruquan Han
Journal:  Trials       Date:  2014-05-10       Impact factor: 2.279

6.  The effect of mannitol on oxidation-reduction potential in patients undergoing deceased donor renal transplantation-A randomized controlled trial.

Authors:  Christian Reiterer; Karin Hu; Samir Sljivic; Markus Falkner von Sonnenburg; Edith Fleischmann; Barbara Kabon
Journal:  Acta Anaesthesiol Scand       Date:  2020-10-15       Impact factor: 2.105

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.